The involvement of IL-10, IL-6, IFN-γ, TNF-α and TGF-β gene polymorphisms among Turkish lung cancer patients

被引:72
作者
Colakogullari, Mukaddes [1 ]
Ulukaya, Engin [1 ]
Oral, Arzu Yilmaztepe [1 ]
Aymak, Figen [2 ]
Basturk, Bilkay [3 ]
Ursavas, Ahmet [4 ]
Oral, H. Barbaros [2 ]
机构
[1] Uludag Univ, Fac Med, Dept Biochem, TR-16059 Gorukle, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Microbiol & Infect Dis, Immunol Unit, TR-16059 Gorukle, Bursa, Turkey
[3] Gazi Univ, Fac Med, Dept Immunol, Ankara, Turkey
[4] Uludag Univ, Fac Med, Chest Dis & Tuberculosis Dept, TR-16059 Gorukle, Bursa, Turkey
关键词
cytokine; genotyping; lung cancer; survival; single nucleotide gene polymorphism (SNP);
D O I
10.1002/cbf.1419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Several genes encoding different cytokines may play crucial roles in host susceptibility to lung cancer, since cytokine production capacity varies among individuals and depends on cytokine gene polymorphisms. The association between cytokine gene polymorphisms with primary lung carcinoma was investigated. DNA samples were obtained from a Turkish population of 44 patients with primary lung cancer, and 59 healthy control subjects. All genotyping (IFN-gamma, TGF-beta 1, TNF-alpha, IL-6 and IL-10) experiments were performed using sequence-specific primers (SSP)-PCR. When compared to the healthy controls, the frequencies of high/intermediate producing genotypes of IL-10 and low producing genotype of TNF-a were significantly more common in the patient group. It is noteworthy that lung cancer patients with the TGF-beta T/T genotype in codon 10 had statistically longer survival compared to those having the C/C genotype (Kaplan-Meier survival function test, log rank significance = 0.014). These results suggest that IL-10, TNF-alpha and TGF-beta 1 gene polymorphisms may affect host susceptibility to lung cancer and the outcome of the patients. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 40 条
[1]
TGF-β antagonists:: Why suppress a tumor suppressor? [J].
Akhurst, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (12) :1533-1536
[2]
Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia [J].
Amirzargar, AA ;
Bagheri, M ;
Ghavamzadeh, A ;
Alimoghadam, K ;
Khosravi, F ;
Rezaei, N ;
Moheydin, M ;
Ansaripour, B ;
Moradi, B ;
Nikbin, B .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2005, 32 (03) :167-171
[3]
Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[4]
TNF-α in promotion and progression of cancer [J].
Balkwill, Frances .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :409-416
[5]
Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma [J].
Bastürk, B ;
Yavasçaoglu, I ;
Vuruskan, H ;
Göral, G ;
Oktay, B ;
Oral, HB .
CYTOKINE, 2005, 30 (01) :41-45
[6]
Cytokine gene polymorphism in human disease: on-line databases [J].
Bidwell, J ;
Keen, L ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 1999, 1 (01) :3-19
[7]
Cytokine gene polymorphism in human disease: on-line databases, Supplement 1 [J].
Bidwell, J ;
Keen, L ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 2001, 2 (02) :61-70
[8]
Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients [J].
Brandacher, Gerald ;
Winkler, Christiana ;
Schroecksnadel, Katharina ;
Margreiter, Ralinund ;
Fuchs, Dietmar .
CURRENT DRUG METABOLISM, 2006, 7 (06) :599-612
[9]
ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[10]
Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867